Printer Friendly

Bone Cancer Global Clinical Trials Review, H1, 2014.

LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Bone Cancer Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/drug_discovery/bone_cancer_global_clinical_trials_review_h1_2014.html

Bone Cancer Global Clinical Trials Review, H1, 2014

Summary GlobalData's clinical trial report, "Bone Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bone Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Bone Cancer 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Unaccomplished Trials of Bone Cancer 25 Subjects Recruited Over a Period of Time 31 Clinical Trials by Sponsor Type 32 Prominent Sponsors 33 Top Companies Participating in Bone Cancer Therapeutics Clinical Trials 34 Prominent Drugs 36 Latest Clinical Trials News on Bone Cancer 37 Jan 03, 2014: Eleison Announces Achievement of Enrollment Milestone in its Phase II Trial of ILC for Pediatric Bone Cancer 37 Oct 22, 2012: Eleison Enrolls First Patient In Phase II Trial Of Cisplatin For Pediatric Bone Cancer 37 Aug 07, 2012: Philips And Celsion Announce FDA Clearance To Commence Phase II Study Of ThermoDox And MR-Guided HIFU In Bone Cancer 37 Mar 02, 2012: Niiki Pharma To Begin Phase I Trial Of NKP-2235 38 Nov 14, 2011: Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy In Bone Cancer Model 38 Clinical Trial Profiles 40 Clinical Trial Overview of Top Companies 40 Novartis AG 40 Clinical Trial Overview of Novartis AG 40 F. Hoffmann-La Roche Ltd. 46 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46 Amgen Inc. 48 Clinical Trial Overview of Amgen Inc. 48 Bayer AG 50 Clinical Trial Overview of Bayer AG 50 Takeda Pharmaceutical Company Limited 52 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 52 Merck & Co., Inc. 53 Clinical Trial Overview of Merck & Co., Inc. 53 Pfizer Inc. 54 Clinical Trial Overview of Pfizer Inc. 54 AstraZeneca PLC 55 Clinical Trial Overview of AstraZeneca PLC 55 Eli Lilly and Company 56 Clinical Trial Overview of Eli Lilly and Company 56 Algeta ASA 57 Clinical Trial Overview of Algeta ASA 57 Clinical Trial Overview of Top Institutes / Government 58 National Cancer Institute 58 Clinical Trial Overview of National Cancer Institute 58 Children's Oncology Group 67 Clinical Trial Overview of Children's Oncology Group 67 The University of Texas M. D. Anderson Cancer Center 70 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 70 Memorial Sloan Kettering Cancer Center 72 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 72 Massachusetts General Hospital 74 Clinical Trial Overview of Massachusetts General Hospital 74 European Organization for Research and Treatment of Cancer 75 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 75 Southwest Oncology Group 76 Clinical Trial Overview of Southwest Oncology Group 76 University Health Network 77 Clinical Trial Overview of University Health Network 77 Stanford University 78 Clinical Trial Overview of Stanford University 78 Five Key Clinical Profiles 79 Appendix 180 Abbreviations 180 Definitions 180 Research Methodology 181 Secondary Research 181 About GlobalData 182 Contact Us 182 Disclaimer 182 Source 183

List of Tables Bone Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7 Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10 Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 Bone Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13 Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14 Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15 Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18 Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Bone Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21 Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22 Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24 Bone Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25 Bone Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26 Bone Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 27 Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31 Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32 Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33 Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35 Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 36 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 46 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 48 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 50 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 52 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 53 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 54 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 55 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 56 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Algeta ASA, 2014* 57 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 58 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 67 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 70 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 72 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 74 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 75 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 76 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 77 Bone Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 78

List of Figures Bone Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10 Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 Bone Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13 Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14 Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15 Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18 Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Bone Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21 Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22 Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24 Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31 Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32 Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33 Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34 Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 36 GlobalData Methodology 181

Read the full report: Bone Cancer Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/drug_discovery/bone_cancer_global_clinical_trials_review_h1_2014.html

For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

SOURCE ReportBuyer
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 2014
Words:2032
Previous Article:Companies Coming Up With Financial Releases -- Research on Lorillard, SunPower, Avnet, and CalAmp.
Next Article:Brenen Hofstadter of Generational Capital Markets, Presents as a Faculty Member at the 2014 International Financial Forum in New York City.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters